Nektar Therapeutics (NKTR) Gross Margin (2010 - 2025)
Nektar Therapeutics' Gross Margin came in at 100.00% for Q4 2025, up 27.34 percentage points from 72.66% a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Gross Margin (2010 - 2025) Analysis & Trends
Going back to Q1 2010, Nektar Therapeutics' Gross Margin data covers 64 quarters.
- Gross Margin carries a five-year change of +12.74 percentage points (FY2020 to FY2025).
- Going back by year, Gross Margin was 68.82% in FY2024 (+6.29 pp), 62.53% in FY2023 (-13.97 pp), 76.50% in FY2022 (+0.93 pp) and 75.57% in FY2021 (-11.69 pp).
- Year-over-year, Gross Margin has increased for six consecutive quarters, with an average year-over-year change of +18.60 percentage points over the last eight quarters.
- The fastest year-over-year change in Gross Margin over five years came in Q2 2025 (a gain of 41.47 percentage points), and the weakest in Q3 2023 (a drop of 30.44 percentage points).
- Business Quant data shows NKTR's Gross Margin at 100.00% (Q3 2025), 100.00% (Q2 2025) and 100.00% (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Nektar Therapeutics | 2.00 Bn | 227.61 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 100.00% |
| Sep 30, 2025 | 100.00% |
| Jun 30, 2025 | 100.00% |
| Mar 31, 2025 | 100.00% |
| Dec 31, 2024 | 72.66% |
| Sep 30, 2024 | 81.62% |
| Jun 30, 2024 | 58.53% |
| Mar 31, 2024 | 60.56% |
| Dec 31, 2023 | 69.51% |
| Sep 30, 2023 | 48.51% |
| Jun 30, 2023 | 65.88% |
| Mar 31, 2023 | 67.31% |
| Dec 31, 2022 | 71.70% |
| Sep 30, 2022 | 78.95% |
| Jun 30, 2022 | 76.30% |
| Mar 31, 2022 | 78.59% |
| Dec 31, 2021 | 75.36% |
| Sep 30, 2021 | 78.69% |
| Jun 30, 2021 | 72.94% |
| Mar 31, 2021 | 75.66% |
API Access
Nektar Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();